Literature DB >> 19604261

The rise and rise of Staphylococcus aureus: laughing in the face of granulocytes.

S Anwar1, L R Prince, S J Foster, M K B Whyte, I Sabroe.   

Abstract

Recent developments in the study of host-pathogen interactions have fundamentally altered our understanding of the nature of Staphylococcus aureus infection, and previously held tenets regarding the role of the granulocyte are being cast aside. Novel mechanisms of pathogenesis are becoming evident, revealing the extent to which S. aureus can evade neutrophil responses successfully by resisting microbicides, surviving intracellularly and subverting cell death pathways. Developing a detailed understanding of these complex strategies is especially relevant in light of increasing staphylococcal virulence and antibiotic resistance, and the knowledge that dysfunctional neutrophil responses contribute materially to poor host outcomes. Unravelling the biology of these interactions is a challenging task, but one which may yield new strategies to address this, as yet, defiant organism.

Entities:  

Mesh:

Year:  2009        PMID: 19604261      PMCID: PMC2730847          DOI: 10.1111/j.1365-2249.2009.03950.x

Source DB:  PubMed          Journal:  Clin Exp Immunol        ISSN: 0009-9104            Impact factor:   4.330


  108 in total

1.  Cutting edge: functional interactions between toll-like receptor (TLR) 2 and TLR1 or TLR6 in response to phenol-soluble modulin.

Authors:  A M Hajjar; D S O'Mahony; A Ozinsky; D M Underhill; A Aderem; S J Klebanoff; C B Wilson
Journal:  J Immunol       Date:  2001-01-01       Impact factor: 5.422

2.  Characterization of Staphylococcus aureus beta-toxin induced leukotoxicity.

Authors:  M J Marshall; G A Bohach; D F Boehm
Journal:  J Nat Toxins       Date:  2000-05

3.  Stimulation of human neutrophils and monocytes by staphylococcal phenol-soluble modulin.

Authors:  W C Liles; A R Thomsen; D S O'Mahony; S J Klebanoff
Journal:  J Leukoc Biol       Date:  2001-07       Impact factor: 4.962

Review 4.  Neutrophil disorders and their management.

Authors:  R Lakshman; A Finn
Journal:  J Clin Pathol       Date:  2001-01       Impact factor: 3.411

5.  Modulation of neutrophil chemokine receptors by Staphylococcus aureus supernate.

Authors:  K E Veldkamp; H C Heezius; J Verhoef; J A van Strijp; K P van Kessel
Journal:  Infect Immun       Date:  2000-10       Impact factor: 3.441

6.  CXC chemokine receptor-2 ligands are required for neutrophil-mediated host defense in experimental brain abscesses.

Authors:  T Kielian; B Barry; W F Hickey
Journal:  J Immunol       Date:  2001-04-01       Impact factor: 5.422

Review 7.  Genetic, biochemical, and clinical features of chronic granulomatous disease.

Authors:  B H Segal; T L Leto; J I Gallin; H L Malech; S M Holland
Journal:  Medicine (Baltimore)       Date:  2000-05       Impact factor: 1.889

8.  Long-term follow-up and outcome of 39 patients with chronic granulomatous disease.

Authors:  J Liese; S Kloos; V Jendrossek; T Petropoulou; U Wintergerst; G Notheis; M Gahr; B H Belohradsky
Journal:  J Pediatr       Date:  2000-11       Impact factor: 4.406

9.  Cutting edge: TLR2-deficient and MyD88-deficient mice are highly susceptible to Staphylococcus aureus infection.

Authors:  O Takeuchi; K Hoshino; S Akira
Journal:  J Immunol       Date:  2000-11-15       Impact factor: 5.422

10.  Role of neutrophil leukocytes in cutaneous infection caused by Staphylococcus aureus.

Authors:  L Mölne; M Verdrengh; A Tarkowski
Journal:  Infect Immun       Date:  2000-11       Impact factor: 3.441

View more
  27 in total

Review 1.  Neutrophil apoptosis: relevance to the innate immune response and inflammatory disease.

Authors:  Sarah Fox; Andrew E Leitch; Rodger Duffin; Christopher Haslett; Adriano G Rossi
Journal:  J Innate Immun       Date:  2010-02-11       Impact factor: 7.349

2.  Antibiotic-loaded nanoparticles targeted to the site of infection enhance antibacterial efficacy.

Authors:  Sazid Hussain; Jinmyoung Joo; Jinyoung Kang; Byungji Kim; Gary B Braun; Zhi-Gang She; Dokyoung Kim; Aman P Mann; Tarmo Mölder; Tambet Teesalu; Santina Carnazza; Salvatore Guglielmino; Michael J Sailor; Erkki Ruoslahti
Journal:  Nat Biomed Eng       Date:  2018-01-22       Impact factor: 25.671

3.  ω-Hydroxyemodin limits staphylococcus aureus quorum sensing-mediated pathogenesis and inflammation.

Authors:  Seth M Daly; Bradley O Elmore; Jeffrey S Kavanaugh; Kathleen D Triplett; Mario Figueroa; Huzefa A Raja; Tamam El-Elimat; Heidi A Crosby; Jon K Femling; Nadja B Cech; Alexander R Horswill; Nicholas H Oberlies; Pamela R Hall
Journal:  Antimicrob Agents Chemother       Date:  2015-02-02       Impact factor: 5.191

Review 4.  Staphylococcus aureus biofilms: properties, regulation, and roles in human disease.

Authors:  Nathan K Archer; Mark J Mazaitis; J William Costerton; Jeff G Leid; Mary Elizabeth Powers; Mark E Shirtliff
Journal:  Virulence       Date:  2011-09-01       Impact factor: 5.882

Review 5.  Th17 cells, Job's syndrome and HIV: opportunities for bacterial and fungal infections.

Authors:  Joshua D Milner; Netanya G Sandler; Daniel C Douek
Journal:  Curr Opin HIV AIDS       Date:  2010-03       Impact factor: 4.283

Review 6.  Are bloodstream leukocytes Trojan Horses for the metastasis of Staphylococcus aureus?

Authors:  Guy E Thwaites; Vanya Gant
Journal:  Nat Rev Microbiol       Date:  2011-02-07       Impact factor: 60.633

7.  Global transcriptome analysis of Staphylococcus aureus biofilms in response to innate immune cells.

Authors:  Tyler D Scherr; Christelle M Roux; Mark L Hanke; Amanda Angle; Paul M Dunman; Tammy Kielian
Journal:  Infect Immun       Date:  2013-09-16       Impact factor: 3.441

8.  Azithromycin in combination with riboflavin decreases the severity of Staphylococcus aureus infection induced septic arthritis by modulating the production of free radicals and endogenous cytokines.

Authors:  Pinky Mal; Kallol Dutta; Debasish Bandyopadhyay; Anirban Basu; Rajni Khan; Biswadev Bishayi
Journal:  Inflamm Res       Date:  2012-11-15       Impact factor: 4.575

Review 9.  Multi-functionalized nanocarriers targeting bacterial reservoirs to overcome challenges of multi drug-resistance.

Authors:  Maria Hassan Kiani; Muhammad Imran; Abida Raza; Gul Shahnaz
Journal:  Daru       Date:  2020-03-19       Impact factor: 3.117

10.  Novel antibody-antibiotic conjugate eliminates intracellular S. aureus.

Authors:  Sophie M Lehar; Thomas Pillow; Min Xu; Leanna Staben; Kimberly K Kajihara; Richard Vandlen; Laura DePalatis; Helga Raab; Wouter L Hazenbos; J Hiroshi Morisaki; Janice Kim; Summer Park; Martine Darwish; Byoung-Chul Lee; Hilda Hernandez; Kelly M Loyet; Patrick Lupardus; Rina Fong; Donghong Yan; Cecile Chalouni; Elizabeth Luis; Yana Khalfin; Emile Plise; Jonathan Cheong; Joseph P Lyssikatos; Magnus Strandh; Klaus Koefoed; Peter S Andersen; John A Flygare; Man Wah Tan; Eric J Brown; Sanjeev Mariathasan
Journal:  Nature       Date:  2015-11-04       Impact factor: 49.962

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.